Clinical Evaluation of Narrow-Diameter Implants Versus Standard-Diameter Implants with Lateral Bone Augmentation in Posterior Jaws: Three-year Results of a Randomized Controlled Trial

Xiao-meng Zhang,Bei-lei Liu,Shu-Jiao Qian,Jun-Yu Shi,Xiao Zhang,Hong-Chang Lai
DOI: https://doi.org/10.1111/clr.14006
2022-01-01
Clinical Oral Implants Research
Abstract:Background The aim of this study was to compare the 3-year clinical outcomes of narrow-diameter implants (NDI) with standard-diameter implants (SDI) in conjunction with lateral bone augmentation in atrophic posterior jaws. Materials and Methods Fifty patients were included and randomly assigned into two groups: Patients in Group 1 received NDI (o3.5 mm); patients in Group 2 received SDI (o4.3 mm) with simultaneous lateral bone augmentation. Implant survival rates, complications, crestal bone loss, peri-implant conditions, treatment cost, and patient satisfaction were compared. Results Three patients dropped out the follow-up. No implant loss was observed. The difference in technical complication rates between the two groups was 3.8% (95% CI: -13.7% to 21.3%). No significant differences in crestal bone loss were found between two groups at 3-year follow-up (0.55 +/- 0.76 vs 0.41 +/- 0.41 mm, p = .429). A total of 20.8% (5/24) of NDI were diagnosed with mucositis and 8.3% (2/24) with peri-implantitis. A total of 17.4% (4/23) of SDI showed mucositis and (1/23) 4.3% showed peri-implantitis. The total cumulative cost of treatment per patient in Group 1 (2849.6 USD, 95% CI: 2726.8-2972.4) was significantly lower than that in Group 2 (3581.4 USD, 95% CI, 3460.9-3701.9) over the 3-year follow-up (p < .01). The patient satisfaction rating of operation was significantly higher in Group 1 (85.42 +/- 7.41 vs 80.48 +/- 7.95, p = .033). Discussion NDI yielded favorable implant survival, acceptable technical and biological complications, and high patient satisfaction supporting single crowns in the atrophic posterior region after 3-year follow-up. NDI might be a reasonable alternative in horizontally deficient posterior jaws. Trial Registration Clinicaltrials.gov identifier: ChiCTR1800020426.
What problem does this paper attempt to address?